{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:45:29Z","timestamp":1787010329094,"version":"build-2736575974"},"reference-count":8,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":["Clin Nucl Med"],"published-print":{"date-parts":[[2021,7]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>\n                    Fragile X-associated tremor\/ataxia syndrome (FXTAS) is a rare movement disorder caused by a 55-to-200 CGG-trinucleotide expansion premutation in the\n                    <jats:italic toggle=\"yes\">FMR1<\/jats:italic>\n                    gene. Core diagnostic criteria are tremor, ataxia, and T2-weighted hyperintensity of the middle cerebellar peduncles on MRI, but FXTAS encompass a broad spectrum of neurological symptoms. FXTAS pathophysiology is largely unknown, and some animal models and neuropathology findings suggest possible overlap with Alzheimer disease. We report the combined PET imaging of a genetically confirmed FXTAS patient, presenting reduced temporal-frontal\n                    <jats:sup>18<\/jats:sup>\n                    F-FDG uptake, and pathological cortical deposition of amyloid to\n                    <jats:sup>18<\/jats:sup>\n                    F-flumetamol PET scan. This report may offer clues to FXTAS pathophysiology.\n                  <\/jats:p>","DOI":"10.1097\/rlu.0000000000003484","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T12:25:58Z","timestamp":1610627158000},"page":"e344-e346","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":4,"title":["Brain 18F-FDG and 18F-Flumetamol PET Imaging of Fragile X-Associated Tremor Ataxia Syndrome"],"prefix":"10.1097","volume":"46","author":[{"given":"Ruggero","family":"Bacchin","sequence":"first","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Salgarello","sequence":"additional","affiliation":[{"name":"Nuclear Medicine Unit, Sacro Cuore Don Calabria Hospital, Negrar"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Trentin","sequence":"additional","affiliation":[{"name":"Neurology Unit, Pederzoli Hospital, Peschiera del Garda, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giampietro","family":"Zanette","sequence":"additional","affiliation":[{"name":"Neurology Unit, Pederzoli Hospital, Peschiera del Garda, Italy."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tamburin","sequence":"additional","affiliation":[{"name":"Department of Neurosciences, Biomedicine and Movement Sciences, University of Verona, Verona"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,1,14]]},"reference":[{"key":"bib1-20250621","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1002\/mds.21493","article-title":"Fragile X-associated tremor\/ataxia syndrome: clinical features, genetics, and testing guidelines","volume":"22","year":"2007","journal-title":"Mov Disord"},{"key":"bib2-20250621","doi-asserted-by":"crossref","first-page":"184","DOI":"10.14802\/jmd.18060","article-title":"Fragile X-associated tremor\/ataxia syndrome: an illustrative case","volume":"12","year":"2019","journal-title":"J Mov Disord"},{"key":"bib3-20250621","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1006\/nbdi.2002.0506","article-title":"Gene expression profiles in a transgenic animal model of fragile X syndrome","volume":"10","year":"2002","journal-title":"Neurobiol Dis"},{"key":"bib4-20250621","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2174\/156720510791050957","article-title":"Fragile X syndrome and Alzheimerr\u2019s disease: another story about APP and beta-amyloid","volume":"7","year":"2010","journal-title":"Curr Alzheimer Res"},{"key":"bib5-20250621","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1212\/WNL.0b013e3182166dc7","article-title":"Autism, Alzheimer disease, and fragile X: APP, FMRP, and mGluR5 are molecular links","volume":"76","year":"2011","journal-title":"Neurology"},{"key":"bib6-20250621","first-page":"360","article-title":"Fragile X mental retardation protein expression in Alzheimer\u2019s disease","volume":"5","year":"2014","journal-title":"Front Genet"},{"key":"bib7-20250621","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/j.1601-183X.2012.00779.x","article-title":"Neuropathological, clinical and molecular pathology in female fragile X premutation carriers with and without FXTAS","volume":"11","year":"2012","journal-title":"Genes Brain Behav"},{"issue":"Pt A","key":"bib8-20250621","first-page":"43","article-title":"Repeat-associated non-AUG (RAN) translation and other molecular mechanisms in fragile X tremor ataxia syndrome","volume":"1693","year":"2018","journal-title":"Brain Res"}],"container-title":["Clinical Nuclear Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003484","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T17:04:18Z","timestamp":1750525458000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/RLU.0000000000003484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,14]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021]]}},"URL":"https:\/\/doi.org\/10.1097\/rlu.0000000000003484","relation":{},"ISSN":["1536-0229","0363-9762"],"issn-type":[{"value":"1536-0229","type":"electronic"},{"value":"0363-9762","type":"print"}],"subject":[],"published":{"date-parts":[[2021,1,14]]}}}